Nascent Biotech, Inc. (NBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0003
-0.0003 (-50.00%)
Aug 22, 2025, 4:00 PM EDT
Nascent Biotech Market Cap
Nascent Biotech has a market cap or net worth of $51.85 thousand as of August 25, 2025. Its market cap has decreased by -99.79% in one year.
Market Cap
51.85K
Enterprise Value
63.46K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 5, 2014, Nascent Biotech's market cap has decreased from 16.24M to 51.85K, a decrease of -99.68%. That is a compound annual growth rate of -40.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 51.85K | -99.41% |
| Dec 31, 2024 | 8.74M | -69.97% |
| Dec 29, 2023 | 29.11M | 19.95% |
| Dec 30, 2022 | 24.27M | 341.66% |
| Dec 31, 2021 | 5.49M | 37.54% |
| Dec 31, 2020 | 3.99M | 18.28% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Glass House Brands | 633.65M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 368.43M |